Three Distraction Techniques for Pain and Anxiety in Children During Allergy Skin Prick Testing
The Effect of Three Different Distraction Techniques on Anxiety and Pain Levels in Children During Allergy Skin Prick Testing: A Randomized Controlled Trial
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Istanbul, Turkey (Türkiye)
- Bakirkoy Dr. Sadi Konuk Research and Training Hospital
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Aged 6-10 years
- Referred for allergy skin prick testing
- Consent of both child and parent
- No analgesic use in the previous six hours
- Able to understand the Wong-Baker FACES Pain Rating Scale and answer the card questions
Exclusion Criteria:
- Neurodevelopmental conditions (diagnosis of autism or intellectual disability)
- Chronic mental, cognitive, or visual problems
- Cognitive, visual, or hearing impairment preventing scale use
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Cartoon group (CG)
Children watched a self-selected, age-appropriate animated cartoon on a tablet computer during the skin prick test.
|
Children watched a self-selected, age-appropriate animated cartoon on a tablet computer during the skin prick test.
|
|
Experimental: DistrACTION® Cards group (DC)
Children viewed DistrACTION® Cards and answered goal-directed visual-search questions asked by the researcher during the skin prick test.
|
Children viewed DistrACTION® Cards and answered goal-directed visual-search questions asked by the researcher during the skin prick test.
|
|
Experimental: Video game group (VG)
Children played a self-selected interactive video game on a tablet with the non-tested arm during the skin prick test.
|
Children played a self-selected interactive video game on a tablet with the non-tested arm during the skin prick test.
|
|
No Intervention: Control group (C)
Children received the clinic's standard protocol; the nurse explained and performed the test, and no additional distraction was provided.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Child-reported procedural pain
Time Frame: During the skin prick test, a procedure lasting approximately 3 minutes
|
Pain self-reported by the child on the Wong-Baker FACES Pain Rating Scale (0 = no pain to 10 = worst possible pain; higher scores indicate more pain).
|
During the skin prick test, a procedure lasting approximately 3 minutes
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Child-reported pain after the procedure
Time Frame: Immediately after the skin prick test, up to 15 minutes after the procedure
|
Pain self-reported by the child on the Wong-Baker FACES Pain Rating Scale (0 = no pain to 10 = worst possible pain; higher scores indicate more pain).
|
Immediately after the skin prick test, up to 15 minutes after the procedure
|
|
Parent-reported pain
Time Frame: During the skin prick test (approximately 3 minutes) and immediately after the procedure (up to 15 minutes)
|
Pain reported by the parent on the Wong-Baker FACES Pain Rating Scale (0 = no pain to 10 = worst possible pain; higher scores indicate more pain).
|
During the skin prick test (approximately 3 minutes) and immediately after the procedure (up to 15 minutes)
|
|
Researcher-reported pain
Time Frame: During the skin prick test (approximately 3 minutes) and immediately after the procedure (up to 15 minutes)
|
Pain reported by the researcher on the Wong-Baker FACES Pain Rating Scale (0 = no pain to 10 = worst possible pain; higher scores indicate more pain).
|
During the skin prick test (approximately 3 minutes) and immediately after the procedure (up to 15 minutes)
|
|
Parent-reported anxiety
Time Frame: Approximately 10 minutes before the skin prick test, during the test (approximately 3 minutes), and immediately after the procedure (up to 15 minutes)
|
Anxiety reported by the parent using the Children's Fear Scale (0 = no anxiety to 4 = severe anxiety; higher scores indicate higher anxiety).
|
Approximately 10 minutes before the skin prick test, during the test (approximately 3 minutes), and immediately after the procedure (up to 15 minutes)
|
|
Researcher-reported anxiety
Time Frame: Approximately 10 minutes before the skin prick test, during the test (approximately 3 minutes), and immediately after the procedure (up to 15 minutes)
|
Anxiety reported by the researcher using the Children's Fear Scale (0 = no anxiety to 4 = severe anxiety; higher scores indicate higher anxiety).
|
Approximately 10 minutes before the skin prick test, during the test (approximately 3 minutes), and immediately after the procedure (up to 15 minutes)
|
|
Interrater agreement
Time Frame: During the skin prick test (approximately 3 minutes) and immediately after the procedure (up to 15 minutes)
|
Intraclass correlation coefficient between child, parent, and researcher ratings.
|
During the skin prick test (approximately 3 minutes) and immediately after the procedure (up to 15 minutes)
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Leyla Erdim, Bakirkoy Dr. Sadi Konuk Research and Training Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 2019-19-01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.